BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesBrandPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsGermany – Non-Exclusive Discount Agreement for Lanreotide
    Awarded contract

    Germany – Non-Exclusive Discount Agreement for Lanreotide

    Awarded
    €1
    Published 2 Jul 2025

    The German Social Code allows health insurance funds and pharmaceutical companies to enter into framework discount agreements for medications covered by statutory health insurance. In accordance with the relevant legal provisions for public procurement, DAK-Gesundheit will conduct a formal procureme

    🇩🇪GermanyPublished 2 Jul 2025· 1 years agoviaTED
    Awarded
    €1
    Published 2 Jul 2025

    Decision brief

    4 fields
    • Contract value
      €1nominal
      Euros
    • Closing date
      Rolling
      No closing date published
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇩🇪Germany

    Suppliers

    1 supplier
    • IP
    IPSEN PHARMA GMBH
    Lead contractor

    Lifecycle

    Awarded

    Contract awarded. Originally published 1 years ago.

    2 July 2025
    Awarded — no open tender advertised

    Brief

    The German Social Code allows health insurance funds and pharmaceutical companies to enter into framework discount agreements for medications covered by statutory health insurance. In accordance with the relevant legal provisions for public procurement, DAK-Gesundheit will conduct a formal procurement process for the active ingredient Lanreotide (ATC H01CB03). DAK-Gesundheit intends to establish discount agreements with all interested pharmaceutical companies for the specified medications related to Lanreotide before new discount agreements come into effect. The discount agreement for Lanreotide will commence on November 1, 2024, and will end on October 31, 2025, with an option to extend for an additional 12 months. The agreement will automatically terminate upon the commencement of an exclusive contract.

    Track record

    2 awards · 2 winners
    Thin record

    Only 2 prior awards here — too little to read.

    In healthcare medical, DAK HEALTH has awarded 2 contracts to 2 suppliers.

    Who wins here
    1. IPSEN PHARMA GMBH1× · 50%
    2. MICRO LABS GMBH1× · 50%

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from DAK HEALTH

    4 listingsView all →
    Environmental Services🇩🇪Germany

    Paper Collection and Document Destruction Services

    This contract opportunity involves the collection of used paper and the destruction of documents and data carriers across Germany. Suppliers are invited to provide services that include the secure destruction of paper, cardboard, and other materials. Detailed specifications of the required services

    DAK HEALTH
    Published 25 Feb 2026
    AwardedIT & Software🇩🇪Germany

    IT Services for DAK Health

    DAK Health is seeking external support for the development of innovative IT solutions in response to the ongoing digital transformation in the German healthcare sector. This need arises from new legal requirements and the challenges posed by a volatile political environment and a shortage of skilled

    €30,000,000DAK HEALTH
    Published 12 Feb 2026
    Healthcare & Medical🇩🇪Germany

    Non-Exclusive Discount Agreement for Adapalene and Benzoyl Peroxide

    This contract involves a non-exclusive discount agreement for the pharmaceutical substances Adapalene and Benzoyl Peroxide, classified under ATC code D10AD23. The agreement is established under Section 130a, Paragraph 8 of the German Social Code (SGB V), allowing health insurance funds and pharmaceu

    €1nominalDAK HEALTH
    Published 14 Dec 2025
    IT & Software🇩🇪Germany

    IT Services for DAK Health

    DAK Health is seeking external support for the development of innovative IT solutions in response to the ongoing digitalization of the German healthcare system and related legal requirements. Due to the volatile political environment and the structural shortage of skilled IT professionals, DAK Healt

    DAK HEALTH
    Published 4 Nov 2025

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇮🇪Ireland

    Occupational Health Services Provider for Ireland

    Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.

    est.€14,878,838IRISH WATER
    Published 24 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Sample Tubes Supply for Blood Testing Services

    NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.

    est.£2,900,000NHS BLOOD AND TRANSPLANT
    Published 23 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Outsourced Dermatology Services for Barking, Havering & Redbridge University Hospital NHS Trust

    BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).

    £520,000indicativeBarking, Havering and Redbridge University Hospitals NHS Trust
    Published 23 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    NHS Framework for Supply of Unlicensed Imported Medicines

    A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.

    £36,095,687indicativeLEEDS TEACHING HOSPITALS NHS TRUST
    Published 23 Sept 2026
    Take action
    View on sourceTED

    Award notice and full record on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    430178-2025
    DH
    Buyer
    DAK HEALTH
    Sector
    Healthcare & Medical